Polyvinyl Alcohol (PVA)-Based Nanoniosome for Enhanced in vitro Delivery and Anticancer Activity of Thymol

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Molani S, Madadi M, Wilkes WJO. A partially observable Markov chain framework to estimate overdiagnosis risk in breast cancer screening: incorporating uncertainty in patients adherence behaviors. Omega. 2019;89:40–53.
   Web of Science ®Google Scholar
• Jain H, Rajendra A, Sengar M, et al. The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL): challenges and considerations. Expert Rev Anticancer Ther. 2022;22(8):845–860. doi:10.1080/14737140.2022.2093718
   PubMed Web of Science ®Google Scholar
• Das CK, Singh SK. Immune Checkpoint Inhibitors in Cancer Therapy: A Ray of Hope, in Biomedical Translational Research. Springer; 2022:393–411.
   Google Scholar
• Molani S, Madadi M, Williams DLJM. Investigating the effectiveness of breast cancer supplemental screening considering radiologists’ bias. MedRxiv. 2020;2020:2020.
   Google Scholar
• Garmarudi AB. Most common techniques of outlier detection. In: Current Applications of Chemometrics. Nova Science; 2015.
   Google Scholar
• Ebrahimi N, Adelian S, Shakerian S, et al. Crosstalk between ferroptosis and the epithelial-mesenchymal transition: implications for inflammation and cancer therapy. Cytokine Growth Factor Rev. 2022;64:33–45. doi:10.1016/j.cytogfr.2022.01.006
   PubMed Web of Science ®Google Scholar
• Namazifard S, Subbarao KJS. Multiple dipole source position and orientation estimation using non-invasive EEG-like signals. Sensors. 2023;23(5):2855. doi:10.3390/s23052855
   PubMed Web of Science ®Google Scholar
• Gezici S, Şekeroğlu N. Current perspectives in the application of medicinal plants against cancer: novel therapeutic agents. Anticancer Agents Med Chem. 2019;19(1):101–111. doi:10.2174/1871520619666181224121004
   PubMed Web of Science ®Google Scholar
• Ahmadi S, Seraj M, Chiani M, et al. In vitro development of controlled-release nanoniosomes for improved delivery and anticancer activity of letrozole for breast cancer treatment. Int J Nanomedicine. 2022;17:6233–6255. doi:10.2147/IJN.S384085
   PubMed Web of Science ®Google Scholar
• Vasan N, Baselga J, Hyman DMJN. A view on drug resistance in cancer. Nature. 2019;575(7782):299–309. doi:10.1038/s41586-019-1730-1
   PubMed Web of Science ®Google Scholar
• Elbe H, Yigitturk G, Cavusoglu T, et al. Apoptotic effects of thymol, a novel monoterpene phenol, on different types of cancer. Bratisl Lek Listy. 2020;121(2):122–128. doi:10.4149/BLL_2020_016
   PubMed Web of Science ®Google Scholar
• Kang S-H, Kim YS, Kim EK, et al. Anticancer effect of thymol on AGS human gastric carcinoma cells. J Microbiol Biotechnol. 2016;26(1):28–37.
   PubMed Web of Science ®Google Scholar
• Haseli S, Pourmadadi M, Samadi A, et al. A novel pH-responsive nanoniosomal emulsion for sustained release of curcumin from a chitosan-based nanocarrier: emphasis on the concurrent improvement of loading, sustained release, and apoptosis induction. Biotechnol Prog. 2022;38(5):e3280. doi:10.1002/btpr.3280
   PubMed Web of Science ®Google Scholar
• Yao Y, Zhou Y, Liu L, et al. Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci. 2020;7:193. doi:10.3389/fmolb.2020.00193
   PubMed Web of Science ®Google Scholar
• Chamani E, Ebrahimi R, Khorsandi K, et al. In vitro cytotoxicity of polyphenols from datura innoxia aqueous leaf-extract on human leukemia K562 cells: DNA and nuclear proteins as targets. Drug Chem Toxicol. 2020;43(2):138–148. doi:10.1080/01480545.2019.1629588
   PubMed Web of Science ®Google Scholar
• Bazzazan S, Moeinabadi-Bidgoli K, Lalami ZA, et al. Engineered UIO-66 metal-organic framework for delivery of curcumin against breast cancer cells: an in vitro evaluation. J Drug Deliv Sci Technol. 2023;79:104009.
   Web of Science ®Google Scholar
• Dastneshan A, Rahiminezhad S, Mezajin MN, et al. Cefazolin encapsulated UiO-66-NH2 nanoparticles enhance the antibacterial activity and biofilm inhibition against drug-resistant S. aureus: in vitro and in vivo studies. Chem Eng J. 2023;455:140544.
   Web of Science ®Google Scholar
• Kazemi M, Emami J, Hasanzadeh F, et al. In vitro and in vivo evaluation of novel DTX-loaded multifunctional heparin-based polymeric micelles targeting folate receptors and endosomes. Recent Pat Anticancer Drug Discov. 2020;15(4):341–359. doi:10.2174/1574892815666201006124604
   PubMed Web of Science ®Google Scholar
• Rezaei T, Rezaei M, Karimifard S, et al. Folic acid-decorated pH-responsive nanoniosomes with enhanced endocytosis for breast cancer therapy: in vitro studies. Front Pharmacol. 2022;13. doi:10.3389/fphar.2022.851242
   PubMed Web of Science ®Google Scholar
• Akbarzadeh I, Fatemizadeh M, Heidari F, Niri NM. Niosomal formulation for co-administration of hydrophobic anticancer drugs into MCF-7 cancer cells. Arch Adv Biosci. 2020;11(2):1–9.
   Google Scholar
• Akbarzadeh I, Saremi Poor A, Yaghmaei S, et al. Niosomal delivery of simvastatin to MDA-MB-231 cancer cells. Drug Dev Ind Pharm. 2020;46(9):1535–1549. doi:10.1080/03639045.2020.1810269
   PubMed Web of Science ®Google Scholar
• Jamshidifar E, Eshrati Yeganeh F, Shayan M, et al. Super magnetic niosomal nanocarrier as a new approach for treatment of breast cancer: a case study on SK-BR-3 and MDA-MB-231 cell lines. Int J Mol Sci. 2021;22(15):7948. doi:10.3390/ijms22157948
   PubMed Web of Science ®Google Scholar
• Amale FR, Ferdowsian S, Hajrasouliha S, et al. Gold nanoparticles loaded into niosomes: a novel approach for enhanced antitumor activity against human ovarian cancer. Adv Powder Technol. 2021;32(12):4711–4722.
   Web of Science ®Google Scholar
• Kazemi M, Emami J, Hasanzadeh F, et al. Pegylated multifunctional pH-responsive targeted polymeric micelles for ovarian cancer therapy: synthesis, characterization and pharmacokinetic study. Int J Polym Mater Polym Biomater. 2021;70(14):1012–1026.
   Web of Science ®Google Scholar
• Ge X, Wei M, He S, et al. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019;11(2):55. doi:10.3390/pharmaceutics11020055
   PubMed Web of Science ®Google Scholar
• Bourbour M, Khayam N, Noorbazargan H, et al. Evaluation of anti-cancer and anti-metastatic effects of folate-PEGylated niosomes for co-delivery of letrozole and ascorbic acid on breast cancer cells. Mol Syst Des Eng. 2022;7(9):1102–1118. doi:10.1016/j.jacbts.2022.05.004
   Web of Science ®Google Scholar
• Rivera-Hernandez G, Antunes-Ricardo M, Martínez-Morales P, et al. Polyvinyl alcohol based-drug delivery systems for cancer treatment. Int J Pharm. 2021;600:120478. doi:10.1016/j.ijpharm.2021.120478
   PubMed Web of Science ®Google Scholar
• Amiri B, Ahmadvand H, Farhadi A, et al. Delivery of vinblastine-containing niosomes results in potent in vitro/in vivo cytotoxicity on tumor cells. Drug Dev Ind Pharm. 2018;44(8):1371–1376. doi:10.1080/03639045.2018.1451880
   PubMed Web of Science ®Google Scholar
• Baranei M, Taheri RA, Tirgar M, et al. Anticancer effect of green tea extract (GTE)-loaded pH-responsive niosome coated with PEG against different cell lines. Mater Today Commun. 2021;26:101751.
   Web of Science ®Google Scholar
• Taherkhani A, Fazli H, Taherkhani F. Application of janus magnetic nanoparticle Fe3O4@ SiN functionalized with beta‐cyclodextrin in thymol drug delivery procedure: an in vitro study. Appl Organomet Chem. 2021;35(11):e6399.
   Web of Science ®Google Scholar
• Karimi E, Abbasi S, Abbasi N, et al. Thymol polymeric nanoparticle synthesis and its effects on the toxicity of high glucose on OEC cells: involvement of growth factors and integrin-linked kinase. Drug Des Devel Ther. 2019;13:2513–2532. doi:10.2147/DDDT.S214454
   PubMed Web of Science ®Google Scholar
• Moghtaderi M, Mirzaie A, Zabet N, et al. Enhanced antibacterial activity of echinacea angustifolia extract against multidrug-resistant Klebsiella pneumoniae through niosome encapsulation. Nanomaterials. 2021;11(6):1573. doi:10.3390/nano11061573
   Web of Science ®Google Scholar
• Akbarzadeh I, Tavakkoli Yaraki M, Bourbour M, et al. Optimized doxycycline-loaded niosomal formulation for treatment of infection-associated prostate cancer: an in-vitro investigation. J Drug Deliv Sci Technol. 2020;57:101715. doi:10.1016/j.jddst.2020.101715
   Web of Science ®Google Scholar
• Fahmy UA, Badr-Eldin SM, Ahmed OA, et al. Intranasal niosomal in situ gel as a promising approach for enhancing flibanserin bioavailability and brain delivery: in vitro optimization and ex vivo/in vivo evaluation. Pharmaceutics. 2020;12(6):485.
   PubMed Web of Science ®Google Scholar
• Al-Mahallawi AM, Fares AR, Abd-Elsalam WH. Enhanced permeation of methotrexate via loading into ultra-permeable niosomal vesicles: fabrication, statistical optimization, ex vivo studies, and in vivo skin deposition and tolerability. AAPS PharmSciTech. 2019;20(5):1–10.
   Web of Science ®Google Scholar
• Zeng W, Li Q, Wan T, et al. Hyaluronic acid-coated niosomes facilitate tacrolimus ocular delivery: mucoadhesion, precorneal retention, aqueous humor pharmacokinetics, and transcorneal permeability. Colloids Surf B Biointerfaces. 2016;141:28–35. doi:10.1016/j.colsurfb.2016.01.014
   PubMed Web of Science ®Google Scholar
• Rochani AK, Balasubramanian S, Ravindran Girija A, et al. Dual mode of cancer cell destruction for pancreatic cancer therapy using Hsp90 inhibitor loaded polymeric nano magnetic formulation. Int J Pharm. 2016;511(1):648–658. doi:10.1016/j.ijpharm.2016.07.048
   PubMedGoogle Scholar
• Akbari J, Saeedi M, Enayatifard R, et al. Curcumin niosomes (curcusomes) as an alternative to conventional vehicles: a potential for efficient dermal delivery. J Drug Deliv Sci Technol. 2020;60:102035. doi:10.1016/j.jddst.2020.102035
   Web of Science ®Google Scholar
• Shaker DS, Shaker MA, Hanafy MS. Cellular uptake, cytotoxicity and in-vivo evaluation of tamoxifen citrate loaded niosomes. Int J Pharm. 2015;493(1–2):285–294. doi:10.1016/j.ijpharm.2015.07.041
   PubMed Web of Science ®Google Scholar
• Noorbazargan H, Mashayekhi A, Khayam N, et al. Anti-cancer, anti-invasiveness & anti-metastasis of green engineered bioorganic-capped silver nanoparticles fabricated from Juniperus chinensis extract and comparison to cisplatin in lung cancer cells (A549): in vitro assessment of cellular and molecular pathways; 2020.
   Google Scholar
• Nowroozi F, Almasi A, Javidi J, et al. Effect of surfactant type, cholesterol content and various downsizing methods on the particle size of niosomes. Iran J Pharm Res. 2018;17(Suppl2):1.
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105(1):1–6.
   Web of Science ®Google Scholar
• García-Manrique P, Machado ND, Fernández MA, et al. Effect of drug molecular weight on niosomes size and encapsulation efficiency. Colloids Surf B Biointerfaces. 2020;186:110711. doi:10.1016/j.colsurfb.2019.110711
   PubMed Web of Science ®Google Scholar
• Kamboj S, Saini V, Bala SJ. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Sci World J. 2014;2014:1.
   Web of Science ®Google Scholar
• Ag Seleci D, Seleci M, Walter JG, Stahl F, Scheper T. Niosomes as nanoparticular drug carriers: fundamentals and recent applications. J Nanomater. 2016;2016:1.
   Web of Science ®Google Scholar
• Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. J Nanomater. 2010;4(4):1.
   Google Scholar
• Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 2014;4(4):1.
   Google Scholar
• Moghassemi S, Parnian E, Hakamivala A, et al. Uptake and transport of insulin across intestinal membrane model using trimethyl chitosan coated insulin niosomes. Mater Sci Eng C Mater Biol Appl. 2015;46:333–340. doi:10.1016/j.msec.2014.10.070
   PubMed Web of Science ®Google Scholar
• Waddad AY, Abbad S, Yu F, et al. Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. Int J Pharm. 2013;456(2):446–458. doi:10.1016/j.ijpharm.2013.08.040
   PubMed Web of Science ®Google Scholar
• Taymouri S, Varshosaz J. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes. Adv Biomed Res. 2016;5. doi:10.4103/2277-9175.178781
   PubMedGoogle Scholar
• Zaki RM, Ali AA, El Menshawe SF, Bary AA. Formulation and in vitro evaluation of diacerein loaded niosomes. Int J Pharm Pharm Sci. 2014;6(Suppl 2):515–521.
   Google Scholar
• Al-Mahallawi AM, Khowessah OM, Shoukri RA. Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment. Int J Pharm. 2014;472(1–2):304–314.
   PubMed Web of Science ®Google Scholar
• Bnyan R, Khan I, Ehtezazi T, et al. Surfactant effects on lipid-based vesicles properties. J Pharm Sci. 2018;107(5):1237–1246. doi:10.1016/j.xphs.2018.01.005
   PubMed Web of Science ®Google Scholar
• Junyaprasert VB, Teeranachaideekul V, Supaperm T. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS pharmscitech. 2008;9:851–859.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerfaces. 2003;30(1–2):129–138.
   Web of Science ®Google Scholar
• Ruckmani K, Sankar V. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech. 2010;11(3):1119–1127. doi:10.1208/s12249-010-9480-2
   PubMed Web of Science ®Google Scholar
• Marianecci C, Rinaldi F, Di Marzio L, et al. Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models. Int J Nanomedicine. 2014;9:635. doi:10.2147/IJN.S55066
   PubMed Web of Science ®Google Scholar
• Huang Y, Chen J, Chen X, et al. PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides. J Mater Sci Mater Med. 2008;19(2):607–614. doi:10.1007/s10856-007-3193-4
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Toyoda T, et al. Physical stability of size controlled small unilameller liposomes coated with a modified polyvinyl alcohol. Int J Pharm. 1998;164(1–2):103–111.
   Web of Science ®Google Scholar
• Khalifa A-ZM, Abdul Rasool BK. Optimized mucoadhesive coated niosomes as a sustained oral delivery system of famotidine. AAPS PharmSciTech. 2017;18(8):3064–3075. doi:10.1208/s12249-017-0780-7
   PubMed Web of Science ®Google Scholar
• Cao Y, Liu F, Chen Y, et al. Drug release from core-shell PVA/silk fibroin nanoparticles fabricated by one-step electrospraying. Sci Rep. 2017;7(1):1–9.
   PubMedGoogle Scholar
• Kayal S, Ramanujan R, C E. Doxorubicin loaded PVA coated iron oxide nanoparticles for targeted drug delivery. Mater Sci Eng C. 2010;30(3):484–490.
   Web of Science ®Google Scholar
• Şanlı O, Karaca I, Işıklan N. Preparation, characterization, and salicylic acid release behavior of chitosan/poly (vinyl alcohol) blend microspheres. J Appl Polym Sci. 2009;111(6):2731–2740.
   Web of Science ®Google Scholar
• Mansoori-Kermani A, Khalighi S, Akbarzadeh I, et al. Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer. Materi Today Bio. 2022;16:100349. doi:10.1016/j.mtbio.2022.100349
   PubMedGoogle Scholar
• Karimifard S, Rezaei N, Jamshidifar E, et al. pH-responsive chitosan-adorned niosome nanocarriers for co-delivery of drugs for breast cancer therapy. ACS Appl Nano Mater. 2022;5(7):8811–8825.
   Google Scholar
• Mohammadi MR, Malkovskiy AV, Jothimuthu P, et al. PEG/dextran double layer influences Fe ion release and colloidal stability of iron oxide nanoparticles. Sci Rep. 2018;8(1):1–11.
   PubMedGoogle Scholar
• Akbarzadeh I, Shayan M, Bourbour M, et al. Preparation, optimization and in-vitro evaluation of curcumin-loaded niosome@calcium alginate nanocarrier as a new approach for breast cancer treatment. Biology. 2021;10(3):173. doi:10.3390/biology10030173
   PubMedGoogle Scholar
• Kishore RSK, Pappenberger A, Dauphin IB, et al. Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis. J Pharm Sci. 2011;100(2):721–731. doi:10.1002/jps.22290
   PubMed Web of Science ®Google Scholar
• Samadi A, Pourmadadi M, Yazdian F, et al. Ameliorating quercetin constraints in cancer therapy with pH-responsive agarose-polyvinylpyrrolidone -hydroxyapatite nanocomposite encapsulated in double nanoemulsion. Int J Biol Macromol. 2021;182:11–25. doi:10.1016/j.ijbiomac.2021.03.146
   PubMed Web of Science ®Google Scholar
• AbuElfadl A, Boughdady M, Meshali M. New peceol™/span™ 60 niosomes coated with chitosan for candesartan cilexetil: perspective increase in absolute bioavailability in rats. Int J Nanomedicine. 2021;16:5581. doi:10.2147/IJN.S324171
   PubMed Web of Science ®Google Scholar
• Balasubramaniam A, Kumar VA, Pillai KS, et al. Formulation and in vivo evaluation of niosome-encapsulated daunorubicin hydrochloride. Drug Dev Ind Pharm. 2002;28(10):1181–1193. doi:10.1081/ddc-120015351
   PubMed Web of Science ®Google Scholar
• Cosco D, Paolino D, Muzzalupo R, et al. Novel PEG-coated niosomes based on bola-surfactant as drug carriers for 5-fluorouracil. Biomed Microdevices. 2009;11(5):1115–1125. doi:10.1007/s10544-009-9328-2
   PubMed Web of Science ®Google Scholar
• Jamali T, Kavoosi G, Safavi M, Ardestani SK. In-vitro evaluation of apoptotic effect of OEO and thymol in 2D and 3D cell cultures and the study of their interaction mode with DNA. Sci Rep. 2018;8(1):1–19.
   PubMedGoogle Scholar
• Blažíčková M, Blaško J, Kubinec R, et al. Newly synthesized thymol derivative and its effect on colorectal cancer cells. Molecules. 2022;27(9):2622. doi:10.3390/molecules27092622
   PubMed Web of Science ®Google Scholar
• Marianecci C, Di Marzio L, Rinaldi F, et al. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci. 2014;205:187–206. doi:10.1016/j.cis.2013.11.018
   PubMed Web of Science ®Google Scholar
• Gude RP, Jadhav MG, Rao SGA, et al. Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model. Cancer Biother Radiopharm. 2002;17(2):183–192. doi:10.1089/108497802753773801
   PubMed Web of Science ®Google Scholar
• Uchegbu IF, Double JA, Kelland LR, et al. The activity of doxorubicin niosomes against an ovarian cancer cell line and three in vivo mouse tumour models. J Drug Target. 1996;3(5):399–409. doi:10.3109/10611869608996831
   PubMed Web of Science ®Google Scholar
• Raudszus B, Mulac D, Langer K. A new preparation strategy for surface modified PLA nanoparticles to enhance uptake by endothelial cells. Int J Pharm. 2018;536(1):211–221. doi:10.1016/j.ijpharm.2017.11.047
   PubMedGoogle Scholar
• De La Chapa JJ, Singha PK, Lee DR, Gonzales CB. Thymol inhibits oral squamous cell carcinoma growth via mitochondria‐mediated apoptosis. J Oral Pathol Med. 2018;47(7):674–682.
   PubMed Web of Science ®Google Scholar
• Carneiro BA, El-Deiry WS. Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol. 2020;17(7):395–417.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Avila G, Sommer B, Mendoza-Posada DA, et al. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit Rev Oncol Hematol. 2019;137:57–83. doi:10.1016/j.critrevonc.2019.02.010
   PubMed Web of Science ®Google Scholar
• Martínez-Alonso D, Malumbres M. Mammalian cell cycle cyclins. In: Seminars in Cell & Developmental Biology. Elsevier; 2020.
   Google Scholar
• Haddadian A, Robattorki FF, Dibah H, et al. Niosomes-loaded selenium nanoparticles as a new approach for enhanced antibacterial, anti-biofilm, and anticancer activities. Sci Rep. 2022;12(1):21938. doi:10.1038/s41598-022-26400-x
   PubMed Web of Science ®Google Scholar
• Seresht HR, Albadry BJ, Al-mosawi AK, Gholami O, Cheshomi H. The cytotoxic effects of thymol as the major component of Trachyspermum ammi on breast cancer (MCF-7) cells. Pharm Chem J. 2019;53:101–107.
   Web of Science ®Google Scholar
• Haghighi A, Shahanipour K, Monajemi R, et al. Evaluation of the cytotoxic effect of thymol loaded chitosan coated Fe3O4 magnetic nanoparticles on MDA-MB-231 cell line and expression of autophagic MAP1LC3A gene. Russ J Bioorg Chem. 2022;2022:1–13.
   Google Scholar
• Gali-Muhtasib H, Hmadi R, Kareh M, et al. Cell death mechanisms of plant-derived anticancer drugs: beyond apoptosis. Apoptosis. 2015;20(12):1531–1562. doi:10.1007/s10495-015-1169-2
   PubMed Web of Science ®Google Scholar
• Balan DJ, Das M, Sathya S, et al. Chitosan based encapsulation increased the apoptotic efficacy of thymol on A549 cells and exhibited non toxic response in Swiss albino mice. Int J Biol Macromol. 2022;202:620–631. doi:10.1016/j.ijbiomac.2022.01.093
   PubMed Web of Science ®Google Scholar
• Matthews HK, Bertoli C, de Bruin RA. Cell cycle control in cancer. Nat Rev Mol Cell Biol. 2022;23(1):74–88.
   PubMed Web of Science ®Google Scholar
• Yamada G, Hagiwara Y, Kimura T, et al. Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese Japanese individuals. Am J Gastroenterol. 2021;116(4):733–748. doi:10.14309/ajg.0000000000001030
   PubMed Web of Science ®Google Scholar
• Islam MT, Khalipha AB, Bagchi R, et al. Anticancer activity of thymol: a literature‐based review and docking study with emphasis on its anticancer mechanisms. IUBMB Life. 2019;71(1):9–19.
   PubMed Web of Science ®Google Scholar
• Avrutsky MI, Troy CM. Caspase-9: a multimodal therapeutic target with diverse cellular expression in human disease. Front Pharmacol. 2021;12:1728.
   Web of Science ®Google Scholar
• Pourgholi A, Dadashpour M, Mousapour A, et al. Anticancer potential of silibinin loaded polymeric nanoparticles against breast cancer cells: insight into the Apoptotic genes targets. Asian Pac J Cancer Prev. 2021;22(8):2587. doi:10.31557/APJCP.2021.22.8.2587
   PubMedGoogle Scholar
• Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8(7):579–591. doi:10.1038/nrd2803
   PubMed Web of Science ®Google Scholar
• Perillo B, Di Donato M, Pezone A, et al. ROS in cancer therapy: the bright side of the moon. Exp Mol Med. 2020;52(2):192–203. doi:10.1038/s12276-020-0384-2
   PubMed Web of Science ®Google Scholar
• Infante E, Castagnino A, Ferrari R, et al. LINC complex-Lis1 interplay controls MT1-MMP matrix digest-on-demand response for confined tumor cell migration. Nat Commun. 2018;9(1):1–13.
   PubMedGoogle Scholar
• Paudel KR, Wadhwa R, Tew XN, et al. Rutin loaded liquid crystalline nanoparticles inhibit non-small cell lung cancer proliferation and migration in vitro. Life Sci. 2021;276:119436. doi:10.1016/j.lfs.2021.119436
   PubMed Web of Science ®Google Scholar
• Pakizehkar S, Ranji N, Naderi Sohi A, et al. Curcumin loaded PEG400‐OA nanoparticles: a suitable system to increase apoptosis, decrease migration, and deregulate miR‐125b/miR182 in MDA‐MB‐231 human breast cancer cells. Polym Adv Technol. 2020;31(8):1793–1804.
   Web of Science ®Google Scholar
• Khorani M, Bobe G, Matthews DG, et al. The impact of the hAPP695 SW transgene and associated amyloid-β accumulation on murine hippocampal biochemical pathways. J Alzheimers Dis. 2022;Preprint:1–19.
   Google Scholar
• Singhal B, Pandey P, Khan F, Singh SK, Kumar T. In vitro elucidation of antiproliferative and apoptotic effects of thymol against prostate cancer LNCaP cells. 2021.
   Google Scholar
• Kumar SR, Thangam R, Vivek R, et al. Synergetic effects of thymoquinone-loaded porous PVPylated Fe3O4 nanostructures for efficient pH-dependent drug release and anticancer potential against triple-negative cancer cells. Nanoscale Adv. 2020;2(8):3209–3221. doi:10.1039/d0na00242a
   PubMed Web of Science ®Google Scholar